Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9062115 Therapeutic factor VIII antibodies

Patent 9062115 was granted and assigned to Novo Nordisk on June, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 3 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 3 Dec, 2023
Edits made to:
Article (+323 characters)
Article

Patent abstract

The present invention relates to therapeutic FVIII antibodies. In particular, the present invention relates to FVIII antibodies having the ability to prolong the circulatory half life of FVIII. The present invention furthermore relates to use of such antibodies in treatment and prophylaxis of haemophilia A.

Edits on 28 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2023
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Heidi Lindgreen Holmberg0
Henrik Oestergaard0
Ida Hilden0
Jes Thorn Clausen0
Kasper Lamberth0
Edits on 22 Jul, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 Jul, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=090621150
Edits on 24 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11654193 Cancer treatment combinations
0
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09062115 Therapeutic factor VIII antibodies US Patent 9062115 Therapeutic factor VIII antibodies

Infobox
Patent Number
090621150
Patent Number
90621150
Edits on 24 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
Novo Nordisk
Novo Nordisk
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
090621150
Date of Patent
June 23, 2015
0
Patent Application Number
138229520
Date Filed
September 15, 2011
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=090621150
Patent Primary Examiner
‌
Marianne P Allen
0
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09062115
Edits on 2 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 2 Jan, 2022
Edits made to:
Infobox (+8 properties)
‌

 US Patent 09062115 Therapeutic factor VIII antibodies

Infobox
Is a
Patent
Patent
Current assignee
Novo Nordisk
Novo Nordisk
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09062115
Date of patent
June 23, 2015
Patent application number
13822952
Date Filed
September 15, 2011
Patent primary examiner
‌
Marianne P Allen

Find more entities like US Patent 9062115 Therapeutic factor VIII antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.